PF-3845

Covalent Inhibitor of FAAH

Structure

Information

  • FAAH
  • Covalent Inhibitor
  • up to 1 uM

In Vitro Validations

Uniprot ID: O00519
Target Class: Lipid metabolism
Target SubClass: Serine Hydrolase
Potency: Kinact, Ki
Potency Value: Kinact 3.3 nM
Potency Assay: enzyme-coupled assay with oleamide as a substrate
PDB ID for probe-target interaction (3D structure): 2WAP 3LJ6
Structure-activity relationship: yes
Target aliases:
Fatty-acid amide hydrolase 1, FAAH1, FAAH, FAAH1_H ...

DOI Reference: 10.1016/j.chembiol.2009.02.013

Uniprot ID: O00519
Target Class: Lipid metabolism
Target SubClass: Serine Hydrolase
Potency: Ki
Potency Value: 230 nM
Potency Assay: enzyme-coupled assay with oleamide as a substrate
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Fatty-acid amide hydrolase 1, FAAH1, FAAH, FAAH1_H ...

DOI Reference: 10.1016/j.chembiol.2009.02.013

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Probe Selectivity in Cell:

Negligible activity against FAAH-2 (IC50>10 mM) in COS-7 cells. Profiled in vivo for FP-rhodamine-labeled brain serine hydrolase activities from mice, no observer inhibition

I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

There are two human FAAH enzymes (FAAH-1 and FAAH-2) that may collaborate to control Fatty Acid Amide catabolism.  There is only a 20% sequence homology between the two enzymes and PF-3845 suffers from an apparent loss of activity against FAAH-2 (IC50>10 μM) in COS-7 cells. Because FAAH-2 can be found in rabbits, this animal may be a more appropriate species to conduct the animal studies.  In addition, the development of a probe that has activity against both enzymes would be more relevant as a chemical probe to model the potential therapy in humans.  An example would be URB597 which inhibits FAAH-2.

(last updated: 4 Jun 2021 )